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The acute crisis with the coronavirus disease of 2019 (COVID-
19) caused by the novel coronavirus Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-COV-2) is the largest biomed-
ical catastrophe of our lifetimes. Like so many other disasters in
the past, such as war, famine, social unrest and economic ca-
lamities, this too shall pass, but it will undoubtedly leave the
world changed. Some of the changes are already evident, but
some are inevitable once we get over this pandemic. In this per-
spective, I provide examples of how the virus is already induc-
ing change in the practice of medicine at large and for
nephrology in particular. As is true for many changes, some
persist after the emergency is over, so I speculate on how ne-
phrology may change once we surmount this predicament
(Figure 1).
COLLABORATION
In the worldwide fight against an invisible enemy, the world has
learned incredible new ways to collaborate. Within days after
the epidemic unfolded in North America, two young physi-
cians, Matthew Sparks and Swapnil Hiremath, curated an anno-
tated resource for use by nephrologists [1]. With a group of
colleagues, they were among the first to address the question of
whether angiotensin-converting enzyme inhibitors or angioten-
sin receptor blockers should be stopped in patients who are tak-
ing these drugs. Their answer—which was to continue to take
these medications—was later supported both by a statement
from the European Society of Cardiology [2] and a scholarly re-
view in theNew England Journal of Medicine [3]. In the context
of the epidemic, under the umbrella of the World Health
Organization, a large randomized worldwide trial was launched
to evaluate outcomes of various drug regimens [4]. Medical
journals collaborated with their readers. For example, JAMA
sent out a call for ideas to conserve personal protective equip-
ment, which was in short supply [5]. Engineers and physicians
collaborated both at Oxford, UK [6] and at the Massachusetts
Institute of Technology (MIT), Cambridge, MA, USA [7] to
innovate low-cost ventilators that they made open source.
The fight against the virus made humans unite, collaborate
and forget their differences—it was a demonstration of global
solidarity.
INNOVATION
As noted above, a ventilator for $100 with an open-source de-
sign developed by a team at MIT is an example of innovation
that had the potential to impact respiratory failure in low- and
middle-income countries. The virus brought the most innova-
tive ideas to the forefront. The first set of tests required to detect
COVID-19 required hours and sometimes days to be reported.
This was impeding the fight against the virus. Abbott
Diagnostics, a Chicago-based company, established a rapid test
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FIGURE 1: Coronavirus—devastation or a new dawn for
nephrology?
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that could be performed using a point-of-care device, most
units of which were already in use in urgent care facilities,
where they were used to diagnose influenza A and B, Strep A
and respiratory syncytial virus [8]. A positive test could be avail-
able in 5min and a negative test in 13min. A low-cost COVID-
19 test was developed in India and the teamwas led by a woman
in late-stage pregnancy; she delivered a baby soon after submit-
ting the test for approval [9]. The cost of this test was one-third
of what was being paid from tests coming from outside the
country.
During the COVID-19 pandemic, a company that makes
Internet-connected thermometers created a map of the USA by
zip code to monitor influenza-like illness [10]. The aggregate,
anonymized map provides different levels of information.
Areas where illness is unusually high indicate early indicators of
COVID-19 spread. Trends are color coded to visualize whether
school closures and social distancing are working. This innova-
tion has the potential to transform the health of dialysis
patients.
Monitoring the health of entire dialysis units across the
country is possible and desirable. With the large wealth of vi-
tal sign and temperature data within each dialysis unit, such
anonymized monitoring may signal early changes in the
health of the unit. Each 1% increase in quarterly influenza-
like illness associates with a 1.5–2.0% increase in all-cause
mortality among dialysis patients. These mortality rates are
similar to mortality estimates for COVID-19 in the general
population. Accordingly, such surveillance efforts may be par-
ticularly valuable to institute measures similar to those imple-
mented in the COVID-19 pandemic [11]. Sharing of such
data will need a national plan and should cross boundaries of
data ownership for societal good. Extending this further, lon-
gitudinal data for individual patients using the algorithms of
artificial intelligence may even provide diagnostic informa-
tion for patients and serve as an early sign of infection or a
cardiovascular event.
TELEMEDICINE
The fight against COVID-19 was not just against the virus. The
deliberate actions taken by large healthcare systems to fight the
virus created another problem. In the face of the pandemic,
most routine medical services were suspended. Because of the
lack of access to routine medical care, patients with chronic
illnesses were now exposed to potential harm. COVID-19
was pushing all other diseases by the wayside, and telemedi-
cine rapidly emerged. Many of the rules that would have
taken years to be approved were passed almost overnight.
Visits to patients using cameras next to the dialysis machine
or by phone were rapidly adopted. Many practices started
seeing patients by telehealth visits.
Could this drive a change in the system? Will patients want
to see their doctor in person or on camera? Or could we have a
hybrid system where many visits might be via telehealth and a
few in person. The answers to these questions are complex and
may be decided by organizations that pay for these services. If
insurance companies pay for these services at a lower rate, but
this lower rate is offset by an increase in volume, it may drive
more telemedicine in the future. However, the behaviors of
physicians and patients will also decide if these changes are
transient or more secular.
DIALYSIS DELIVERY
COVID-19, being a droplet-borne viral infection, necessitated so-
cial distancing and required patients to be dialyzed in a manner
that reduced the risk of viral transmission to other dialysis
patients in the same unit. One option was to dialyze such patients
at home. Thus home-based systems—instead of in-center dialysis
requiring centralized water delivery systems—may emerge.
Receiving self-care dialysis during catastrophes may make more
sense for our patients and may enter the lexicon when planning
care for patients reaching end-stage renal disease. Patients may
therefore lean toward home therapies such as peritoneal dialysis
or home hemodialysis, instead of in-center dialysis.
The increase in patients with multi-organ failure requiring
acute dialysis posed another challenge to the system. Acute
peritoneal dialysis has not been adopted in dialysis units, but
the scarcity of resources led to resurrection of a technique that
had almost been forgotten. Low-volume continuos veno-ve-
nous hemofiltration (CVVH) delivery was adopted due to the
adequate supply of replacement solutions. Whether such inter-
ventions help or hurt can only be answered by future analyses,
and even then, causality would be difficult to deduce. However,
such data may challenge the paradigm of high-volume CVVH
currently practiced.
The push to monitor the patient remotely without entering
the room was acutely felt during this epidemic. Baby monitors
were installed in patient’s rooms to communicate with patients.
Given that acute respiratory distress syndrome was an impor-
tant feature of the disease, the need to monitor vital signs was
never felt more acutely. These needs may drive innovation in
remote monitoring systems that may benefit dialysis patients
directly by noninvasively monitoring the hemodynamic state
on a beat-to-beat basis.
VIRTUAL LEARNING AND CONFERENCES
Virtual learning became the norm for entire universities—
almost overnight—and there was no time to prepare. Local
teaching conferences were often held by videoconferenc-
ing. Large conferences, for example, the National Kidney
Foundation and ERA-EDTA, became fully virtual. These
unprecedented changes provide new opportunities for hy-
brid conferences, where a mix of virtual and physical con-
ferences may happen. Such virtual conferences have the
potential to allow participation of physicians from low-
and middle-income countries and for those unable or un-
willing to travel.
DISASTER PREPAREDNESS
The Ebola virus epidemic was a wake-up call for disaster pre-
paredness, but it did not gain traction because of its limited im-
pact on society. The COVID-19 pandemic is so widespread that
disaster preparedness is inevitable. Like the fire drill, we may
well have drills for such disasters in the future.
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A stockpiling of personal protective equipment, N95 respira-
tors and surgical masks and engineering controls are bound to
emerge. While stockpiling may be necessary, it should not be
reactive and should be carefully considered. For example, it
may be more sensible to have such stockpiles at a national or
state level in order to conserve resources.
Preparedness by dialysis chains to dedicate units or areas for
such emergencies will emerge. Reduced reliance on central wa-
ter delivery systems and increased performance of dialysis in in-
dividual rooms with the aid of innovative machines such as one
that uses a cartridge to remove toxins is also likely [12].
Disaster preparedness would be remiss if it did not consider
an equitable distribution of healthcare workforce resources dur-
ing a pandemic. A global response to the availability of physi-
cians, nurses, dialysis technicians and other providers would
smooth out shortages. For example, if Italy faces a shortage of
medical personnel, there should be a pool of physicians and
providers who would be available to address this shortage from
other countries. The medical licensing boards are likely to
change in the face of this crisis.
INFECTION CONTROL
Nephrologists and other healthcare workers became acutely
aware of social distancing; donning and doffing masks, gloves
and gowns; and hand hygiene. Behaviors learned in the time of
crisis were closely followed not just to protect patients, but also
the health of the caregiver. Hand hygiene, discovered by the
Hungarian physician Ignaz Semmelweis >150 years ago, is not
universal among healthcare workers. However, this behavior is
likely to stay. If so, we can expect to see a decrease in prevent-
able infections such as exit-site infections, catheter-related bac-
teremia and peritonitis.
SOCIAL DETERMINANTS OF HEALTH
Homelessness, hunger and job insecurity are important deter-
minants of health outcomes. The marginalized in society were
not only exposed to a greater risk of COVID-19, but also had a
greater barrier to receive medical attention due to the closure of
routine visits. Social distancing taxed the shelters in which they
were housed. Maps were created for the entire USA based on
social determinants of health to identify populations at greater
risk for COVID-19 [13]. Medical students in Pittsburgh volun-
teered to deliver medications at home [14]. In the state of
California, with an estimated 130 000 homeless, many were
provided with hotel rooms or trailers [15]. The impact of the
homeless on society was never felt more acutely than at the
time of the pandemic. COVID-19 induced a change in societal
attitudes toward the homeless overnight. Will this change in so-
cietal attitudes and approaches to health persist after the crisis
is over? We can hope so.
RESEARCH
Some changes are already evident. For example, the Food and
Drug Administration issued new guidance for research during
the pandemic and approved diagnostic tests in a matter of days.
It also approved within a matter of days emergency use
authorization for the use of imported anesthesia gas machines
modified for use as ventilators. Trials of vaccines and drugs
were fast-tracked. But the future of research is moot.
In a 2015 Ted Talk, ’The next outbreak?We’re not ready’, Bill
Gates speculated rather accurately that it is not a nuclear disaster
but a virus that will kill more of humanity [16]. Yet globally, the
allocation of national budgets to healthcare is often a fraction of
defense budgets. If our society recognizes that a more realistic
enemy we face is an infection—and not a nuclear war—it may
dedicate more resources to healthcare as a deterrent to this ca-
lamity. If we so decide, then the resources to study and prevent
such pandemics are the most likely beneficiaries. Hopefully there
will be the political will to bolster the healthcare infrastructure,
including research funding that is needed to predict, prevent and
fight not only such pandemics, but also diseases such as chronic
kidney disease that claimmore lives than a pandemic.
CONCLUSIONS
When the pandemic is over, we will remember the vulnerability
we faced, but perhaps more important we will remember the
humility, courage and compassion that we witnessed. Our re-
spect for people will grow, especially those who worked the
frontlines, such as dialysis technicians, nurses and allied health
workers, ambulance drivers and environmental health workers.
They showed up for work every day to take care of patients who
were fighting the virus. We will recognize that we could not
have surmounted this pandemic alone; we needed their assis-
tance. We will recognize and respect those who showed us the
way forward, the people who forecasted the number of days for
lockdowns and social distancing and those who made the criti-
cal decisions to keep society safe. We will also remember those
who separated the fake news from real science with their scien-
tific knowledge. For example, the social media amplification of
COVID-19 was enormous and fact-checking by those trained
in research methods and interpretation could inform the public
about propaganda or false claims.
This is not the last time that the human race will face a pan-
demic. What we learn from this pandemic will decide how pre-
pared we will be to face the next one. The answer to the
question posed in the title is speculative, but I predict that
Coronavirus will induce a rapid change in nephrology. In the
end, we may wonder if all that was left behind by Corona was
death and destruction—an eclipse—or was it a vibrant halo. In
my view, nephrology will emerge stronger and better if we dis-
play the same solidarity we did while we fought the virus.
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